Citadel Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Buy |
178,155
+75,227
| +73% | +$54.5K | ﹤0.01% | 5172 |
|
|
2025
Q1 | $88.6K | Sell |
102,928
-117,292
| -53% | -$101K | ﹤0.01% | 5195 |
|
|
2024
Q4 | $370K | Buy |
220,220
+140,881
| +178% | +$237K | ﹤0.01% | 4314 |
|
|
2024
Q3 | $226K | Buy |
79,339
+17,761
| +29% | +$50.6K | ﹤0.01% | 4530 |
|
|
2024
Q2 | $144K | Buy |
61,578
+5,953
| +11% | +$13.9K | ﹤0.01% | 4796 |
|
|
2024
Q1 | $164K | Sell |
55,625
-59,293
| -52% | -$174K | ﹤0.01% | 4877 |
|
|
2023
Q4 | $344K | Buy |
114,918
+107,860
| +1,528% | +$323K | ﹤0.01% | 4105 |
|
|
2023
Q3 | $22.3K | Buy |
7,058
+2,316
| +49% | +$7.32K | ﹤0.01% | 5288 |
|
|
2023
Q2 | $18.4K | Buy |
+4,742
| New | +$18.4K | ﹤0.01% | 5276 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6323 |
|
|
2022
Q4 | – | Sell |
-63,062
| Closed | -$134K | – | 6483 |
|
|
2022
Q3 | $134K | Buy |
63,062
+28,412
| +82% | +$60.4K | ﹤0.01% | 5011 |
|
|
2022
Q2 | $93K | Sell |
34,650
-23,815
| -41% | -$63.9K | ﹤0.01% | 5322 |
|
|
2022
Q1 | $254K | Buy |
58,465
+42,827
| +274% | +$186K | ﹤0.01% | 5091 |
|
|
2021
Q4 | $81K | Sell |
15,638
-21,254
| -58% | -$110K | ﹤0.01% | 6010 |
|
|
2021
Q3 | $226K | Buy |
+36,892
| New | +$226K | ﹤0.01% | 5300 |
|
|
2021
Q2 | – | Sell |
-302,610
| Closed | -$4.17M | – | 6831 |
|
|
2021
Q1 | $4.17M | Buy |
302,610
+2,610
| +0.9% | +$36K | ﹤0.01% | 2320 |
|
|
2020
Q4 | $3.26M | Sell |
300,000
-5,677
| -2% | -$61.6K | ﹤0.01% | 2126 |
|
|
2020
Q3 | $3.28M | Buy |
+305,677
| New | +$3.28M | ﹤0.01% | 1836 |
|